Positive impact of omega-3 fatty acid supplementation in a dog with drug-resistant epilepsy: A case study

Epilepsy and Behavior

Volumn 15, Issue 4, 2009, Pages 527-528

  Scorza, Fulvio A ^a   Cavalheiro, Esper A ^a   Arida, Ricardo M ^a   Terra, Vera C ^b   Scorza, Carla A ^a   Ribeiro, Miriam O ^c   Cysneiros, Roberta M ^c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c MACKENZIE PRESBYTERIAN UNIVERSITY   (Brazil)

Author keywords

Dogs; Epilepsy; Heart; Omega 3; Sudden death

Indexed keywords

OMEGA 3 FATTY ACID; PHENOBARBITAL; POTASSIUM BROMIDE;

ARTICLE; CLONUS; DIET SUPPLEMENTATION; DOG DISEASE; DRUG EFFICACY; EPILEPSY; FEMALE; NONHUMAN; TONIC CLONIC SEIZURE; UNCONSCIOUSNESS;

ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; DIETARY SUPPLEMENTS; DOG DISEASES; DOGS; DRUG RESISTANCE; EPILEPSY; FATTY ACIDS, OMEGA-3; FEMALE; PHENOBARBITAL;

EID: 67849108283     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2009.05.013     Document Type: Article

References (15)

1. Chang B.S., and Lowenstein D.H. Epilepsy. N Engl J Med 349 (2003) 1257-1266
2. Sander J.W. Some aspects of prognosis in the epilepsies: a review. Epilepsia 34 (1993) 1007-1016
3. Chandler K. Canine epilepsy: what can we learn from human seizure disorders?. Vet J 172 (2006) 207-217
4. Podell M., and Fenner W.R. Bromide therapy in refractory canine idiopathic epilepsy. J Vet Intern Med 7 (1993) 318-327
5. Dowling P.M. Management of canine epilepsy with phenobarbital and potassium bromide. Can Vet J 35 (1994) 724-725
6. Scorza F.A., Cysneiros R.M., Arida R.M., Terra-Bustamante V.C., de Albuquerque M., and Cavalheiro E.A. The other side of the coin: beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy. Epilepsy Behav 13 (2008) 279-283
7. Yuen A.W., and Sander J.W. Is omega-3 fatty acid deficiency a factor contributing to refractory seizures and SUDEP? A hypothesis. Seizure 13 (2004) 104-107
8. Yuen A.W., Sander J.W., Fluegel D., et al. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy Behav 7 (2005) 253-258
9. Ferrari D., Cysneiros R.M., Scorza C.A., et al. Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: quantification with immunohistochemical for calcium-binding proteins. Epilepsy Behav 13 (2008) 36-42
10. DeGiorgio C.M., and Miller P. n-3 fatty acids (eicosapentanoic and docosahexanoic acids) in epilepsy and for the prevention of sudden unexpected death in epilepsy. Epilepsy Behav 13 (2008) 712-713
11. Calon F., and Cole G. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostaglandins Leukot Essent Fatty Acids 77 (2007) 287-293
12. Ohara K. The n-3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 469-474
13. Bourre J.M. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J Nutr Health Aging 8 (2004) 163-174
14. Schlanger S., Shinitzky M., and Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 43 (2002) 103-104
15. Gaby A.R. Natural approaches to epilepsy. Altern Med Rev 12 (2007) 9-24